Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 149 of 151

  1. rF1V-1018

    United Therapeutics Europe Ltd

    Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersenia Pestis

    phase 2 mab active

    1 trial

  2. rF1V-1018

    United Therapeutics Europe Ltd

    Plague, Pneumonic

    phase 2 mab completed

    1 trial

  3. rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Dermatitis, Allergic Contact

    phase 2 small molecule completed

    1 trial

  4. rTMS (repetitive transcranial magnetic stimulation)

    CNS Pharmaceuticals

    Obsessive-Compulsive Disorder

    phase 2 other active

    1 trial

  5. rVA576

    Akari Therapeutics Plc

    Keratoconjunctivitis, Atopic

    phase 2 small molecule terminated

    1 trial

  6. rVA576

    Akari Therapeutics Plc

    Bullous Pemphigoid (BP)

    phase 2 small molecule completed

    1 trial

  7. radiation therapy

    Children's Hospital of Fudan University

    Brain Tumor

    phase 2 other completed

    1 trial

  8. raltitrexed combined with apatinib

    Chinese PLA General Hospital

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  9. ranibizumab

    CUMBERLAND PHARMACEUTICALS INC

    Retinal Vein Occlusion

    phase 2 small molecule completed

    1 trial

  10. rapcabtagene autoleucel

    Novartis Pharmaceuticals

    Scleroderma, Diffuse

    phase 2 mab active

    1 trial

  11. rasagiline mesylate

    Teva Pharma GmbH

    Multiple System Atrophy

    phase 2 small molecule completed

    1 trial

  12. real-tDCS with MI-BCI

    Hospital Authority, Hong Kong

    Stroke

    phase 2 other completed

    1 trial

  13. recombinant human Angiostatin protein

    CASI Pharmaceuticals

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule completed

    1 trial

  14. recombinant human endostatin

    Peking University Third Hospital

    Melanoma

    phase 2 small molecule active

    1 trial

  15. recombinant human erythropoietin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypoxic-Ischemic Encephalopathy

    phase 2 small molecule completed

    1 trial

  16. recombinant human erythropoietin (rhEpo)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infant, Premature

    phase 2 small molecule active

    1 trial

  17. recombinant human growth hormone

    Affiliated Hospital of Jiangnan University

    Phelan-McDermid Syndrome

    phase 2 small molecule completed

    1 trial

  18. recombinant humanized anti-CD25 monoclonal antibody

    The First People's Hospital of Lianyungang

    Transfusion Dependent Thalassemia

    phase 2 small molecule active

    1 trial

  19. relaxin

    Ultragenyx UK Limited

    Systemic Sclerosis

    phase 2 small molecule completed

    1 trial

  20. remicade (anti tumor necrosis factor inhibitor)

    Hospital Authority, Hong Kong

    Takayasu's Arteritis

    phase 2 small molecule active

    1 trial

  21. rencofilstat, 75 mg

    Hepion Pharmaceuticals

    NASH With Fibrosis

    phase 2 small molecule completed

    1 trial

  22. retinal pigment epithelium transplantation

    The First People's Hospital of Lianyungang

    Dry Age-related Macular Degeneration

    phase 2 mab active

    1 trial

  23. rezatapopt

    PMV Pharmaceuticals

    Advanced Solid Tumor

    phase 2 small molecule active

    1 trial

  24. rhASA

    Shire

    Late Metachromatic Leukodystrophy (MLD)

    phase 2 small molecule active

    1 trial

  25. rhASA

    Shire

    Late Metachromatic Leukodystrophy (MLD)

    phase 2 small molecule active

    1 trial

  26. rhGM-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pulmonary Alveolar Proteinosis

    phase 2 small molecule active

    1 trial

  27. rhHNS-10 mg

    Takeda

    Sanfilippo Syndrome

    phase 2 mab terminated

    1 trial

  28. rhIGF-1/rhIGFBP-3

    Takeda

    Retinopathy of Prematurity (ROP)

    phase 2 small molecule completed

    1 trial

  29. rhIGF-I/rhIGFBP-3

    Takeda

    Retinopathy of Prematurity (ROP)

    phase 2 small molecule completed

    1 trial

  30. ribavirin (RBV)

    Boehringer Ingelheim

    Hepatitis C

    phase 2 small molecule completed

    1 trial

  31. ribose

    Ultragenyx UK Limited

    5'-Nucleotidase Syndrome

    phase 2 small molecule completed

    1 trial

  32. riliprubart

    Sanofi-aventis Healthcare Pty Ltd

    Chronic inflammatory demyelinating polyradiculoneuropathy

    phase 2 small molecule active

    1 trial

  33. riliprubart, riliprubart

    Sanofi-aventis Healthcare Pty Ltd

    Transplant Rejection

    phase 2 small molecule active

    1 trial

  34. risperidone

    Ultragenyx UK Limited

    Tourette Syndrome

    phase 2 small molecule completed

    1 trial

  35. rituximab

    Children's Hospital of Fudan University

    Lymphoproliferative Disorder

    phase 2 mab completed

    1 trial

  36. rituximab

    Chinese University of Hong Kong

    Systemic Lupus Erythematosus

    phase 2 small molecule completed

    1 trial

  37. rituximab

    Ultragenyx UK Limited

    Purpura, Thrombocytopenic, Idiopathic

    phase 2 small molecule completed

    1 trial

  38. rituximab

    United Therapeutics Europe Ltd

    Lymphoma

    phase 2 mab completed

    1 trial

  39. rituximab /Dexamethasone/cyclophosphamide

    The First People's Hospital of Lianyungang

    Treatment

    phase 2 small molecule active

    1 trial

  40. sabirnetug

    Acumen Pharmaceuticals

    Alzheimer Disease

    phase 2 small molecule active

    1 trial

  41. sapablursen

    IONIS PHARMACEUTICALS INC

    Beta Thalassemia Intermedia

    phase 2 small molecule terminated

    1 trial

  42. sapablursen

    IONIS PHARMACEUTICALS INC

    Phlebotomy Dependent Polycythemia Vera

    phase 2 small molecule active

    1 trial

  43. sapropterin

    BioMarin Pharmaceutical Australia Pty Ltd

    Autistic Disorder

    phase 2 small molecule completed

    1 trial

  44. sarcosine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  45. sarilumab

    Sanofi-aventis Healthcare Pty Ltd

    Systemic Juvenile Idiopathic Arthritis (sJIA)

    phase 2 small molecule active

    1 trial

  46. saxagliptin

    KYOWA KIRIN AUSTRALIA PTY LTD

    Diabetes, Type 2

    phase 2 small molecule completed

    1 trial

  47. scAAV8OTC

    Ultragenyx UK Limited

    Ornithine Transcarbamylase (OTC) Deficiency

    phase 2 gene therapy completed

    1 trial

  48. scAAV9/AGA

    Ultragenyx UK Limited

    Aspartylglucosaminuria

    phase 2 gene therapy active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.